Indication expansion

NetraMark and Juvenescence extend collaboration

Partnership sees AI platform expanded into drug repurposing and discovery. Canadian AI technology firm NetraMark yesterday announced the extension of its NetraPharma collaboration agreement with...

Calico licenses memory-enhancing drug ISRIB

A new drug known as ISRIB which reverses Down's Syndrome memory deficits in mice has been licensed to Google’s Calico for aging research. In 2016...

New study shows rapamycin slows Alzheimer’s

A new study from UT Health San Antonio suggests the drug rapamycin may be able to slow the rate of brain-related blood flow decreases. The...

Anti-aging metformin brain drug works – but only in women!

Could metformin be made for women? The Longevity drug on the side of girl power. A new study has demonstrated that while metformin may have...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.